N. Verlinden
发表
M. Kanwar,
Hayah Kassis-George,
N. Verlinden,
2022,
Therapeutics and clinical risk management.
S. Kane-Gill,
J. Coons,
C. Iasella,
2017,
Journal of cardiovascular pharmacology and therapeutics.
J. Coons,
K. Swetz,
R. Anguiano,
2021,
Pulmonary circulation.
R. Benza,
A. Raina,
N. Verlinden,
2020,
Journal of pharmacy practice.
R. Benza,
N. Badie,
A. Raina,
2019,
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
M. Kanwar,
A. Raina,
N. Verlinden,
2019,
The Annals of pharmacotherapy.
J. Coons,
N. Verlinden,
James C. Coons,
2015,
Pharmacotherapy.
M. Kanwar,
Hayah Kassis-George,
N. Verlinden,
2022
.
N. Verlinden,
C. Konopka,
Mareena Shuster,
2022,
ASAIO journal.
Robert Soltis,
Nathan Verlinden,
Nicholas Kruger,
2015,
American Journal of Pharmaceutical Education.
R. Benza,
A. Raina,
N. Verlinden,
2020,
Pulmonary circulation.
A. Raina,
Nael Aldweib,
N. Verlinden,
2021,
Pulmonary circulation.
R. Anguiano,
A. Kimber,
A. Schmit,
2022,
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND.
K. Goel,
M. Brener,
M. Kanwar,
2023,
JACC. Heart failure.